Spectrum Pharmaceuticals Inc expected to post a loss of 15 cents a share - Earnings Preview

Spectrum Pharmaceuticals

09/11/2022 03:03

* Spectrum Pharmaceuticals Inc  SPPI.OQ   SPPI.O  is
expected
to show no change in quarterly revenue when it reports 
results on November 10. 
    * 
    * ​Refinitiv's mean analyst estimate for Spectrum
Pharmaceuticals
Inc is for a loss of 15 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Spectrum
Pharmaceuticals Inc is $3.5​, above​ its last closing price
of $0.42. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.15       -0.16      -0.17     Missed  -7.6
 Mar. 31 2022  -0.20       -0.19      -0.08     Beat    58.3
 Dec. 31 2021              -0.21      -0.26     Missed  -21.5​
 Sep. 30 2021  -0.28       -0.28      -0.21     Beat    25
 ​​Jun.        -0.25       -0.25      -0.32     Missed  -25.5
 30 2021                                                
 Mar. 31 2021  -0.30       -0.31      -0.25     Beat    20.6​
 Dec. 31 2020              -0.29      -0.29     Met     0
 Sep. 30 2020  -0.35       -0.35      -0.37     Missed  -5.7
 This summary was machine generated November 9 at 03:02 GMT.  All
figures in US dollars  unless otherwise stated